Genotypic and phenotypic relationships in Burkholderia cepacia isolated from cystic fibrosis patients and the environment

Journal of Applied Microbiology

Volumn 86, Issue 3, 1999, Pages 460-468

  Wigley, P ^a,b   Burton, N F ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS;

ANTIBIOTICS RESISTANCE; BURKHOLDERIA CEPACIA; CLINICAL STRAINS; CYSTIC FIBROSIS; ENVIRONMENTAL ISOLATES; ENVIRONMENTAL STRAIN; GENETIC VARIABILITY; PCR-RIBOTYPING; PHENOTYPIC VARIATIONS;

TISSUE;

ANTIBIOTIC AGENT; CEFTAZIDIME; GENTAMICIN; PIPERACILLIN; SULFAMETHOXAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; ENVIRONMENT; GENETIC VARIABILITY; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONION; PHENOTYPE; POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE;

ALLIUM CEPA; ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; NEGIBACTERIA;

EID: 0033003201     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.1999.00687.x     Document Type: Article

References (36)

1. Acar, J.F. and Goldstein, F.W. (1985) Disk susceptibility test. In Antibiotics in Laboratory Medicine ed. Lorian, V.L. Baltimore: Williams & Wilkins.
2. Bevivino, A., Tabbacchoni, S., Chiarini, L., Carusi, M.V., Del Gallo, M. and Visca, P. (1994) Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia. Microbiology 140, 1069-1076.
3. BioRad Laboratories (1992) Chef DR-II Pulsed Field Gel Electrophoresis systems: Instruction Manual and Applications Guide. Hercules, California: BioRad Laboratories.
4. Burkholder, W.H. (1950) Sour skin: a bacterial rot of onion bulbs. Phytopathology 40, 115-117.
5. Butler, S.L., Doherty, C.J., Hughes, J.E., Nelson, J.W. and Govan, J.R.W. (1995) Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? Journal of Clinical Microbiology 33, 1001-1004.
6. Cazzola, G., Amalfitano, G., Tonelli, E., Perazzoli, C., Piacenti, I. and Mastella, G. (1996) Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Acta Paediatrica 85, 554-557.
7. Davidson, D.J., Dorin, J.R., McLachlan, G. et al. (1995) Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nature Genetics 9, 351-357.
8. Fisher, M.C., LiPuma, J.J., Dasen, E. et al. (1993) Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. Journal of Pediatrics 123, 745-747.
9. Gonzalez and Vidaver, A.K. (1979) Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin. Journal of General Microbiology 110, 161-170.
10. Govan, J.R.W., Hughes, J.E. and Vandamme, P. (1996) Burkholderia cepacia: medical, taxonomic and ecological issues. Journal of Medical Microbiology 45, 395-407.
11. Grouthes, D., Koopman, U., Von Der Hardt, H. and Tummler, B. (1988) Genome fingerprinting of Pseudomonas aeruginosa indicates colonization with closely related strains. Journal of Clinical Microbiology 26, 1973-1977.
12. Hagedoorn, C., Gould, W.D., Bardinelli, T.R. and Gustavson, D.R. (1987) A selective medium for enumeration and recovery of Pseudomonas cepacia biotypes from soil. Applied and Environmental Microbiology 53, 2265-2268.
13. Henry, D.A., Campbell, M.E., LiPuma, J.J. and Speert, D.F. (1997) Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. Journal of Clinical Microbiology 35, 614-619.
14. Johnson, W.M., Tyler, S.D. and Rozee, K.R. (1994) Linkage analysis of geographic and clinical Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. Journal of Clinical Microbiology 32, 924-930.
15. Kado, C.I. and Liu, S.T. (1981) Rapid procedure for the detection and isolation of large and small plasmids. Journal of Bacteriology 145, 1365-1373.
16. Lelliott, R.A. and Stead, D.E. (1987) Methods for the Diagnosis of Bacterial Diseases of Plants. Oxford: British Society for Plant Pathology/Black well Science.
17. Lennon, E. and DeCicco, B.T. (1991) Plasmids of Pseudomonas cepacia of diverse origins. Applied and Environmental Microbiology 57, 2345-2350.
18. Macrina, F.L., Kopecko, D.J., Jones, K.R., Ayers, D.J. and McCowen, S.M. (1978) A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1, 417-420.
19. Morris, M. and Roberts, J. (1959) A group of pseudomonads able to synthesize poly-β-hydroxyburyric acid. Nature 183, 1538-1539.
20. Mortensen, J.E., Fisher, M. and LiPuma, J.J. (1995) Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infection Control and Hospital Epidemiology 16, 30-32.
21. Pegues, D.A., Carson, L.A., Anderson, R.L. et al. (1993) Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clinical Infectious Diseases 16, 407-411.
22. Pegues, C.F., Pegues, D.A., Ford, D.S. et al. (1996) Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiology and Infection 116, 407-411.
23. Pitt, T.L., Kaufmann, M.E., Patel, P.S., Benge, L.C.A., Gaskin, S. and Livermore, D.M. (1996) Type characterisation and antibiotic susceptibility of Burkholderia cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. Journal of Medical Microbiology 44, 203-210.
24. Revets, H., Vandamme, P., Van Zeebroeck, A. et al. (1996) Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clinica Belgica 51, 222-230.
25. Rochelle, P.A., Fry, J.C., Day, M.J. and Bale, M.J. (1985) An accurate method for estimating sizes of small and large plasmids and DNA fragments by gel electrophoresis. Journal of General Microbiology 132, 53-59.
26. Ryley, H.C., Millar-Jones, L., Paull, A. and Weeks, J. (1995) Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. Journal of Medical Microbiology 43, 436-441.
27. Ryley, H.C., Ojeniyi, B., Hoiby, N. and Weeks, J. (1996) Lack of evidence of nosocomial cross-infection by Burkholderia cepacia amongst Danish cystic fibrosis patients. European Journal of Clinical Microbiology 15, 755-758.
28. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
29. Threlfall, E.T., Rowe, B., Ferguson, J.L. and Ward, L.R. (1986) Characterization of Salmonella typhimurium phage type 204e isolated in Britain. Journal of Hygeine 97, 419-426.
30. Ursing, J.B., Rossello-Mora, R.A., Garcia-Valdes, E. and Lalaucat, J. (1995) Taxonomic note: a pragmatic approach to the nomenclature of phenotypically similar genetic groups. International Journal of Systematic Bacteriology 45, 604.
31. Vandamme, P. (1995) Emerging new 'Pseudomonas' species in cystic fibrosis. Twentieth European Cystic Fibrosis Conference, Brussels, Belgium, 18-25 June 1995.
32. Vandamme, P., Holmes, B., Vancanneyt, M. et al. (1997) Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. International Journal of Systematic Bacteriology 47, 1188-1200.
33. Vandepitte, J., Engbaek, K., Piot, P. and Heuk, C.C. (1991) Basic Laboratory Procedures in Clinical Bacteriology. Geneva: World Health Organization.
34. Wigley, P. (1998) Characterisation of Burkholderia cepacia of Clinical and Environmental Origins. PhD Thesis, University of Wales Institute Cardiff.
35. Wilkinson, S.G. and Pitt, T.L. (1995) Burkholderia (Pseudomonas) cepacia: pathogenicity and resistance. Reviews in Medical Microbiology 6, 10-17.
36. Wise, M.G., McArthur, J.V., Wheat, C. and Shimkets, L.J. (1996) Temporal variation in genetic diversity and structure of a lotic population of Burkholderia cepacia. Applied and Environmental Microbiology 62, 1558-1562.